AN2 Therapeutics, Inc. 10-Q filing
Filed 2025-08-12 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0000950170-25-107301
- Form type
- 10-Q
- CIK
- 0001880438
- Primary document
- https://www.sec.gov/Archives/edgar/data/1880438/000095017025107301/antx-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AN2 Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-18.8M | - | - |
| Net Income | $-17.1M | - | - |
| Eps Basic | -0.57 | - | - |
| Eps Diluted | -0.57 | - | - |
| Cash And Equivalents | $18.2M | - | - |
| Total Assets | $75.8M | - | - |
| Total Liabilities | $7.0M | - | - |
| Shareholders Equity | $68.8M | - | - |
| Operating Cash Flow | $-18.2M | - | - |